Spark Investment Management LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 79 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 44.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2013$185,00041,6000.05%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2013.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders